GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kolmar Holdings Co 024720.KS · KRW

Consumer Staples · KRX · 🇰🇷 South Korea

Compare

8,200

-1.20%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Kolmar Holdings Co

Its shares trade on KRX under the ticker 024720.KS. It has been listed since 9 April 2002. In the fiscal year to 31 December 2025, it reported revenue of ₩630.11bn and net income of ₩23.44bn. At that date it held total assets of ₩1.29trn and shareholders' equity of ₩614.81bn.

Kolmar Korea Holdings Co., Ltd. designs and manufactures cosmetics and pharmaceuticals. The company is headquartered in Sejong, Sejong. The company went IPO on 2002-04-09. Through its subsidiaries, the Company engages in the original development and design manufacturing (ODM) of cosmetics; original equipment manufacturing (OEM) of pharmaceuticals, leasing of real estates, as well as manufacturing of health foods and others. The Company’s major subsidiaries include KOREA KOLMAR CO.,LTD., Kolmarpharma Co.,Ltd. and others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
9 Apr 2002

Leadership

Pay as last reported

  • Dong Han YoonChairman of the Board, since 2019
  • Mr. Sang Hyeon YoonChief Executive Officer, Director, since 2005
  • Mr. Hyeon Gyu ChoiVice President
  • Don Seon GwonManaging Director
  • Yong Gi HongManaging Director
  • Jin Jun KimManaging Director
  • Jin Yeong KimManaging Director
  • Shin Gyu KimManaging Director
  • Jin Wun LeeManaging Director
  • Yi Pyo HongAssistant Managing Director, since 2011
  • Cheol Gyu ChoiAssistant Managing Director
  • Yeong Sik GilAssistant Managing Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Kolmar Korea Holdings Co., Ltd. excels in cosmetics and pharmaceuticals ODM and OEM manufacturing.
  • KOREA KOLMAR CO., LTD. and Kolmarpharma Co., Ltd. drive strong product development.
  • Sejong headquarters supports efficient operations in Consumer Staples sector.

Weaknesses

  • Limited focus on real estate leasing may reduce revenue diversification.
  • Reliance on ODM and OEM models could limit brand recognition.
  • Sejong city location might restrict access to global markets.

Opportunities

  • Expanding health food manufacturing aligns with growing wellness trends.
  • KOREA KOLMAR CO., LTD. can leverage new market segments in Asia.
  • Pharmaceutical OEM opportunities in the Korean market are promising.

Threats

  • Competition in cosmetics ODM sector may increase pricing pressure.
  • Regulatory changes in pharmaceuticals could affect OEM operations.
  • Economic downturns might reduce consumer spending on cosmetics.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.